학술논문
The polycomb group protein BMI-1 inhibitor PTC-209 is a potent anti-myeloma agent alone or in combination with epigenetic inhibitors targeting EZH2 and the BET bromodomains
Document Type
Article
Author
Source
In: Oncotarget . (Oncotarget, 2017, 8(61):103731-103743)
Subject
Language
English
ISSN
19492553